One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/43392

Title:	One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes
Authors:	Cao, Davide VRANCKX, Pascal Valgimigli, Marco Sartori, Samantha Angiolillo, Dominick J. Bangalore, Sripal Bhatt, Deepak L. Feng, Yihan Ge, Junbo Hermiller, James Makkar, Raj R. Neumann, Franz -Josef Saito, Shigeru Picon, Hector Toelg, Ralph Maksoud, Aziz Chehab, Bassem M. Choi, James W. Campo, Gianluca Hernandez, Jose M. de la Torre Krucoff, Mitchell W. Kunadian, Vijay Sardella, Gennaro Spirito, Alessandro Thiele, Holger Varenne, Olivier Vogel, Birgit Zhou, Yujie Windecker, Stephan Mehran, Roxana
Issue Date:	2024
Publisher:	EUROPA EDITION
Source:	EuroIntervention, 20 (10) , p. e630 -e642
Abstract:	A short dual antiplatelet therapy (DAPT) duration has been proposed for patients at high bleeding risk (HBR) undergoing drug-eluting coronary stent (DES) implantation. Whether this strategy is safe and effective after a non-ST-segment elevation acute coronary syndrome (NSTE-ACS) remains uncertain.
Keywords:	ACS/NSTE-ACS;adjunctive pharmacotherapy;bleeding;drug-eluting stent;myocardial infarction
Document URI:	http://hdl.handle.net/1942/43392
ISSN:	1774-024X
e-ISSN:	1969-6213
DOI:	10.4244/EIJ-D-23-00658
ISI #:	001257469900005
Rights:	Europa Digital & Publishing 2024. All rights reserved.
Category:	A1
Type:	Journal Contribution
Appears in Collections:	Research publications

File	Description	Size	Format
xx.pdf	Peer-reviewed author version	672.12 kB	Adobe PDF	View/Open
EIJ-D-23-00658_Cao.pdf Restricted Access	Published version	386.78 kB	Adobe PDF	View/Open Request a copy

1

checked on Aug 23, 2025

1

checked on Aug 25, 2025

Check